Correction: Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Correction: Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers ; volume:43 ; number:25 ; day:29 ; month:5 ; year:2024 ; pages:1972 ; date:6.2024
Oncogene ; 43, Heft 25 (29.5.2024), 1972, 6.2024
- Creator
-
Sun, Bowen
Mason, Seth
Wilson, Robert C.
Hazard, Starr E.
Wang, Yubao
Fang, Rong
Wang, Qiwei
Yeh, Elizabeth S.
Yang, Meixiang
Roberts, Thomas M.
Zhao, Jean J.
Wang, Qi
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41388-024-02999-1
- URN
-
urn:nbn:de:101:1-2408210856289.213333301444
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sun, Bowen
- Mason, Seth
- Wilson, Robert C.
- Hazard, Starr E.
- Wang, Yubao
- Fang, Rong
- Wang, Qiwei
- Yeh, Elizabeth S.
- Yang, Meixiang
- Roberts, Thomas M.
- Zhao, Jean J.
- Wang, Qi
- SpringerLink (Online service)
Other Objects (12)
Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers
Bioprocessing technologies in biorefinery for sustainable production of fuels, chemicals, and polymers
Job change in urban China : an assessment of socialist employment relationship
Stability of numerical solution for partial differential equations with piecewise constant arguments
Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers
The landscape of d16HER2 splice variant expression across HER2-positive cancers
Targeting HER3 or MEK overcomes acquired Trastuzumab resistance in HER2-positive gastric cancer-derived xenograft
New FTY720-docetaxel nanoparticle therapy overcomes FTY720-induced lymphopenia and inhibits metastatic breast tumour growth
Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers
San cai tu hui : 106 juan, 21
San cai tu hui : 106 juan, 6
Return Migration of Foreign Students
Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers
Bioprocessing technologies in biorefinery for sustainable production of fuels, chemicals, and polymers
Job change in urban China : an assessment of socialist employment relationship
Stability of numerical solution for partial differential equations with piecewise constant arguments
Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers
The landscape of d16HER2 splice variant expression across HER2-positive cancers
Targeting HER3 or MEK overcomes acquired Trastuzumab resistance in HER2-positive gastric cancer-derived xenograft
New FTY720-docetaxel nanoparticle therapy overcomes FTY720-induced lymphopenia and inhibits metastatic breast tumour growth
Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers
San cai tu hui : 106 juan, 21
San cai tu hui : 106 juan, 6
Return Migration of Foreign Students
Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers
Bioprocessing technologies in biorefinery for sustainable production of fuels, chemicals, and polymers
Job change in urban China : an assessment of socialist employment relationship
Stability of numerical solution for partial differential equations with piecewise constant arguments
Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers
The landscape of d16HER2 splice variant expression across HER2-positive cancers
Targeting HER3 or MEK overcomes acquired Trastuzumab resistance in HER2-positive gastric cancer-derived xenograft
New FTY720-docetaxel nanoparticle therapy overcomes FTY720-induced lymphopenia and inhibits metastatic breast tumour growth
Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers
San cai tu hui : 106 juan, 21
San cai tu hui : 106 juan, 6